News

Under the terms of the agreement, Bioceros will be a pre-approved cell line generation partner for licensees of the PER.C6 cell line located in the EU. Other terms

This study is a randomized blinded study comparing the rates of gastric and duodenal mucosal damage, measured by endoscopy, between PL 2200 and 325mg aspirin at the preferred

Under the terms of the agreement, GlaxoSmithKline (GSK) will assume all development responsibility and associated costs for IDX899, and Idenix will receive an upfront payment of $34 million

PPD has licensed the development rights for dapoxetine to Alza, a Janssen-Cilag affiliate. Under terms of the agreement, PPD will receive a $2.5 million milestone payment for each

The clinical trial is a Phase IIa double blind, placebo controlled, multi-center dose ranging study to evaluate the safety and preliminary efficacy of AZX100 in trocar sites of

Dr Schoenberg will assist the company in its current effort to complete critical clinical trials with the Sonablate 500 technology in the treatment of patients with prostate cancer.

The Cayman product family is comprised of multiple implant systems, including a buttress plate to address graft expulsion, a lower lumbar sacral plate, and additional plating designs to

The new agreement extends the most recent agreement for an additional three years with two consecutive one year renewal options. The Bioject drug vial adapter is a needle-free

Sodium-dependent glucose co-transporter type 2 (SGLT2) is the major transporter responsible for glucose re-absorption in the kidney. Decreasing SGLT2 levels promote glucose excretion in the urine and reduce